Science news, opinion, interviews and product reports for scientists across all disciplines. Make Scientist Live my homepage  SciLive on Twitter20th November 2009

BookMark


Search

 

Readers Poll


Yes
No
Undecided


View Results »

Subscribe

Subscribe to Scientist Live

Click here for FREE subscription to eLab and eFood magazines

 

Newsletter

RSS Feed

Get the Scientist Live RSS Feed
RSS Feed

Visit our Products and Services Section


ITCM is a global manufacturer and leading innovator in customised machinery and systems for pharmaceutical packaging and processing.
eLab 2009-5-15 Issue

 View online magazine
 
 


eFood 2009-10-01 Issue

 View online magazine
 

eLab - Biotechnology

Another boost to the immune system

Immunologists have discovered how to manipulate the immune system to increase its power and protect the body from successive viral infections.

Published in the current edition of Viral Immunology, these findings may point the way toward developing new and more effective vaccines against diseases like influenza or HIV and enhance new developments in immunology.

The study suggests that scientists can boost the body’s resistance and fend off successive viral infections by taking components of the virus and indirectly activating specific populations of killer T cells – the body’s virus-killing cells.  The virus components are introduced through a process known as cross priming whereby virus molecules are engulfed by immune cells to activate killer T cells.

“With this mechanism in mind, we can develop better tools to make more successful and effective vaccines,” says Sam Basta, Queen’s professor of Microbiology and Immunology, and the principal investigator of the study. The other members of the research team are master’s students Attiya Alatery and Erin Dunbar.

The researchers hope to build on their findings by next studying which immune cells do a better job of protecting the body while using this mechanism.

“The answer to this question is like having the Holy Grail of immunotherapy and vaccine design within our grasp,” says Dr. Basta.
 
Dr. Basta suggests that by fully understanding this new mechanism, researchers should be able to shuttle the appropriate viral components to the right immune cells.

 

©2008 Setform Limited

Site By OWB